127 related articles for article (PubMed ID: 10460812)
1. Diurnal variation in the metabolism of S-carboxymethyl-L-cysteine in humans.
Steventon GB
Drug Metab Dispos; 1999 Sep; 27(9):1092-7. PubMed ID: 10460812
[TBL] [Abstract][Full Text] [Related]
2. Identification of thiodiglycolic acid, thiodiglycolic acid sulfoxide, and (3-carboxymethylthio)lactic acid as major human biotransformation products of S-carboxymethyl-L-cysteine.
Hofmann U; Eichelbaum M; Seefried S; Meese CO
Drug Metab Dispos; 1991; 19(1):222-6. PubMed ID: 1673403
[TBL] [Abstract][Full Text] [Related]
3. Phenylalanine hydroxylase: possible involvement in the S-oxidation of S-carboxymethyl-l-cysteine.
Boonyapiwat B; Forbes B; Steventon GB
Anal Biochem; 2004 Dec; 335(1):91-7. PubMed ID: 15519575
[TBL] [Abstract][Full Text] [Related]
4. The metabolism of S-carboxymethyl-L-cysteine in man: isolation of an ester glucuronic acid conjugate from urine.
Waring RH; Mitchell SC; Shah RR
Xenobiotica; 1983 May; 13(5):311-7. PubMed ID: 6636828
[TBL] [Abstract][Full Text] [Related]
5. Human phenylalanine monooxygenase and thioether metabolism.
Boonyapiwat B; Panaretou B; Forbes B; Mitchell SC; Steventon GB
J Pharm Pharmacol; 2009 Jan; 61(1):63-7. PubMed ID: 19126298
[TBL] [Abstract][Full Text] [Related]
6. Lack of congruence between cysteine dioxygenase activity and S-carboxymethyl-L-cysteine S-oxidation activity in rat cytosol.
Khan S; Mitchell SC; Steventon GB
J Pharm Pharmacol; 2004 Aug; 56(8):993-1000. PubMed ID: 15285843
[TBL] [Abstract][Full Text] [Related]
7. The pharmacokinetics of orally administered S-carboxymethyl-L-cysteine in the dog, calf and sheep.
Panagopoulos P; Forbes B; Mitchell SC; Steventon GB
Eur J Pharm Sci; 2010 Feb; 39(4):219-23. PubMed ID: 20035864
[TBL] [Abstract][Full Text] [Related]
8. The metabolism and elimination of S-carboxymethyl-L-cysteine in man.
Waring RH; Mitchell SC
Drug Metab Dispos; 1982; 10(1):61-2. PubMed ID: 6124385
[TBL] [Abstract][Full Text] [Related]
9. S-carboxymethyl-L-cysteine and it (R/S)-S-oxides in beagle dog plasma and hepatic cytosol.
Panagopoulos P; Mitchell SC; Steventon GB
Xenobiotica; 2015; 45(12):1047-53. PubMed ID: 26068525
[TBL] [Abstract][Full Text] [Related]
10. S-carboxymethyl-L-cysteine.
Mitchell SC; Steventon GB
Drug Metab Rev; 2012 May; 44(2):129-47. PubMed ID: 22497630
[TBL] [Abstract][Full Text] [Related]
11. Identification of S-(carboxymethyl)-L-cysteine and thiodiglycolic acid, urinary metabolites of 2,2'-bis-(chloroethyl)-ether in the rat.
Müller G; Norpoth K; Eckard R
Cancer Lett; 1979 Sep; 7(5):299-305. PubMed ID: 509409
[TBL] [Abstract][Full Text] [Related]
12. Determination of specific urinary thioethers derived from acrylonitrile and ethylene oxide.
Gérin M; Tardif R; Brodeur J
IARC Sci Publ; 1988; (89):275-8. PubMed ID: 3198210
[TBL] [Abstract][Full Text] [Related]
13. An investigation into possible xenobiotic-endobiotic inter-relationships involving the amino acid analogue drug, S-carboxymethyl-L-cysteine and plasma amino acids in humans.
Steventon GB; Mitchell SC; Angulo S; Barbas C
Amino Acids; 2012 May; 42(5):1967-73. PubMed ID: 21559953
[TBL] [Abstract][Full Text] [Related]
14. Capillary electrophoretic determination of S-carboxymethyl-L-cysteine and its major metabolites in human urine: feasibility investigation using on-column detection of non-derivatized solutes in capillaries with minimal electroosmosis.
Tanaka Y; Thormann W
Electrophoresis; 1990 Sep; 11(9):760-4. PubMed ID: 2257847
[TBL] [Abstract][Full Text] [Related]
15. Thiodiglycolic acid and dermatological reactions following S-carboxymethyl-L-cysteine administration.
Steventon GB; Mitchell SC
Br J Dermatol; 2006 Feb; 154(2):386-7. PubMed ID: 16433823
[No Abstract] [Full Text] [Related]
16. Phenylalanine 4-monooxygenase and the role of endobiotic metabolism enzymes in xenobiotic biotransformation.
Steventon GB; Mitchell SC
Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1213-21. PubMed ID: 19653802
[TBL] [Abstract][Full Text] [Related]
17. Thiodiglycolic acid as a possible causative agent of fixed drug eruption provoked only after continuous administration of S-carboxymethyl-L-cysteine: case report and review of reported cases.
Adachi A; Sarayama Y; Shimizu H; Yamada Y; Horikawa T
Br J Dermatol; 2005 Jul; 153(1):226-8. PubMed ID: 16029368
[No Abstract] [Full Text] [Related]
18. Oxidative deamination of carboxyethyl-cysteine and carboxymethyl-homocysteine.
Rinaldi A; Fadda MB; De Marco C
Physiol Chem Phys; 1978; 10(1):47-57. PubMed ID: 724799
[TBL] [Abstract][Full Text] [Related]
19. Degradation to sulphate of S-methyl-L-cysteine sulphoxide and S-carboxymethyl-L-cysteine sulphoxide in man.
Waring RH; Harris RM; Steventon GB; Mitchell SC
Drug Metabol Drug Interact; 2003; 19(4):241-55. PubMed ID: 14768973
[TBL] [Abstract][Full Text] [Related]
20. Tracing the human metabolism of stable isotope-labelled drugs by ex vivo NMR spectroscopy. A revision of S-carboxymethyl-L-cysteine biotransformation.
Meese CO; Fischer P
Z Naturforsch C J Biosci; 1990; 45(11-12):1171-5. PubMed ID: 2095787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
